Redcare Pharmacy stock gains with fresh Xetra highs as Vienna listing shows rising market value
Published on 08/27/2026 at 16:29 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Redcare Pharmacy (NL0012044747) stock traded at €66.50 on Xetra on August 27, 2026, marking a solid daily advance in heavy trading as investors continued to reprice the online pharmacy's growth prospects based on recent performance and sector dynamics. On the same day, a parallel listing in Vienna reflected a market capitalization above €1.3 billion, highlighting how the company has secured a sizable position among European mid-cap e-commerce and healthcare names in a relatively short period.
According to a detailed Xetra quote page for August 27, 2026, Redcare Pharmacy shares changed hands at €66.50 at 3:18 p.m. local time, with intraday bids and offers clustered between €66.40 and €66.75. The same trading summary reported a day volume of 2.58 million shares on Xetra alone, confirming that the stock is actively traded and that liquidity is sufficient for institutional and retail investors alike.
Market data highlight rising valuations
In addition to the Xetra data, a daily statistics table from the Vienna market showed that Redcare Pharmacy NV, identified by ISIN NL0012044747, closed at €63.35 on August 27, 2026, after gaining 3.43 percent in that session. The same table listed a daily high of €63.40 and a low of €62.15, giving investors a clear view of that day's trading range on the Vienna venue and showing that the stock held most of its intraday gains into the close.
The Vienna statistics also indicated that Redcare Pharmacy's total market capitalization stood at €1,303,641,070 in that session, placing the stock in the global market segment of the Vienna platform and emphasizing that the company now commands a valuation in excess of €1.3 billion. For investors who focus on cross-listed European mid caps, this figure helps benchmark Redcare Pharmacy against peers in online retail and healthcare-related e-commerce and provides a concrete measure of the company's equity footprint at the end of August 2026.
Trading dynamics and cross-venue comparison
The Xetra overview for August 27, 2026, showed that Redcare Pharmacy stock posted a daily gain of 4.97 percent at the €66.50 level, underscoring that the move was not marginal but a clearly quantified advance. The same quote table recorded 771 individual trades on Xetra and noted that other venues such as Tradegate, LS Exchange, Stuttgart, Frankfurt, and gettex were simultaneously quoting prices between €65.40 and €66.55, indicating a tight spread and consistent pricing across the German market landscape.
Comparing the Xetra and Vienna data reveals a modest venue-based price difference: while Xetra showed €66.50 at 3:18 p.m. on August 27, 2026, the Vienna table listed €63.35 as the last price with a separate local high and low, both aligned with that venue's order book. This comparison suggests that, despite minor cross-venue differentials, Redcare Pharmacy shares are broadly trading in the low- to mid-€60s across continental Europe, and the 3.43 percent daily gain in Vienna complements the 4.97 percent advance documented on the Xetra platform.
Historical short interest context
A short interest overview updated on August 27, 2026, but referencing historical data, lists an entry dated August 27, 2025, where a specific holder reported a 0.64 percent short position with a notional exposure of €9 million. While this figure is explicitly tied to the prior year, it offers historical context on how some market participants previously positioned themselves against Redcare Pharmacy, even as the company's valuation and trading levels have since moved higher.
It is important for investors to distinguish between such historical short interest data and current positioning, as the August 27, 2025, snapshot does not directly describe today's short exposure but rather shows that the stock was on the radar of hedge funds and other sophisticated traders one year earlier. In combination with today's €66.50 Xetra price and over €1.3 billion market capitalization in Vienna, this underscores how perceptions of risk and opportunity in Redcare Pharmacy have evolved over the past twelve months.
Business model and online pharmacy offering
Redcare Pharmacy operates as a leading online pharmacy and e-commerce platform focused on prescription medicines, over-the-counter healthcare products, and wellness items for customers in several European markets. The company typically combines centralized warehousing, digital prescription handling, and customer-facing apps to streamline the process of ordering medicines, which are then delivered directly to patients at home, often supported by national health insurance schemes or prescription reimbursement systems depending on local regulations.
Beyond core prescription medicines, Redcare Pharmacy's catalog extends to vitamins, dietary supplements, personal care products, and medical devices, making the platform a one-stop shop for many health-related needs. This model allows the company to benefit from cross-selling opportunities, such as offering complementary wellness products alongside recurring prescription orders, and to collect data on customer preferences, which can be used to optimize inventory, tailor promotions, and refine logistics planning.
Representative online product example
One representative category in Redcare Pharmacy's product lineup is over-the-counter vitamin and mineral supplements sold under various brands through its online storefront. These products typically target everyday wellness needs such as immune support, energy metabolism, or bone health, and they can be added to a user's basket alongside prescription refills or other medical supplies. For many customers, this combination of essential medicines and optional wellness products delivered in a single shipment provides both convenience and cost efficiency, reinforcing the company's value proposition.
Stock price context at the end of August 2026
As of the Xetra quote timestamp of August 27, 2026, 3:18 p.m. local time, Redcare Pharmacy stock traded at €66.50, while Vienna's closing data showed €63.35 and a market capitalization of €1,303,641,070 for the same date. These numbers frame the company's equity valuation and trading range at the end of August 2026 and demonstrate that, despite venue-specific price nuances, Redcare Pharmacy shares are firmly established in the European mid-cap bracket in the low- to mid-€60s per share.
Fact box
Company: Redcare Pharmacy NV
ISIN: NL0012044747
Ticker: RDC
Exchange: Xetra / Vienna (global market segment)
Price (as of August 27, 2026, 3:18 p.m. local time): €66.50
Market cap: €1.30 billion (as of August 27, 2026)
Sector / Industry: Online pharmacy / E-commerce healthcare
Index membership: SDAX-related European mid cap
